MBody AI Ltd.
- MBAI
- NASDAQ
- Biotechnology
- Capsule-Based Diagnostics
- GI Screening
$2.37
Today −14.00%Quote Oct 19, 2026, 04:09 PM UTC
−56.62%over the last month
Max drawdown −57.0%From 1-month high −57.0%3 months −58.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About MBody AI
MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation. The company's platform provides Perception AI for computer vision and environmental understanding, Cognitive AI for adaptive decision-making, and Learning AI for continuous on-site machine learning.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
85
Founded
2004
Market value
$16.6M
Quote Oct 19
Analyst target
$10.00
+322.8% from here
Resistance
$2.59
9.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MBAIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free